Sitagliptin/metformin

Sitagliptin/metformin
Combination of
Sitagliptin Dipeptidyl peptidase-4 inhibitor
Metformin Biguanide
Clinical data
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration		 Oral
ATC code A10BD07 (WHO)
Legal status
Legal status
Identifiers

Sitagliptin/metformin (trade name Janumet) is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin.


This article is issued from Wikipedia - version of the 1/29/2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.